Skandinaviska Enskilda Banken Ab (Publ) Ptc Therapeutics, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$38.16 - $48.86 $66,054 - $84,576	-1,731 Reduced 4.59%	35,945 $1.74 Million
Q4 2022 Feb 08, 2023	SELL	$33.53 - $54.79 $73,195 - $119,606	-2,183 Reduced 5.48%	37,676 $1.44 Million
Q2 2021 Aug 10, 2021	BUY	$37.95 - $49.37 $390,277 - $507,721	10,284 Added 34.77%	39,859 $1.69 Million
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $1.38 Million - $2.04 Million	29,575 New	29,575 $1.4 Million

228

78.1M

144K

54.8K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.53B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.